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Relatively buried antigenic determinants of T-globulin revealed by pepsin 
digestion which react with human anti-T-globulin factors were first described 
by Osterland, Harboe,  and Kunkel (1).  Subsequent observations (2,  3)  have 
emphasized  that  these  anti-T-globulin  factors  showing  specificity  for  the 
pepsin  site  are  often  associated  with  sera  containing  so-called  "anti-anti- 
bodies" (4--6). During a  study of human sera containing anti--T-globulin fac- 
tors showing specificity for sites revealed on T-globulin by pepsin digestion, 
evidence for marked autospecificity was obtained. Although no prozones have 
been noted in several reports  concerning this class  of anti-'y-globulin factors 
(1-3,  7),  studies  outlined below produced  evidence that patients  possessing 
high titers of antibody reacting with ceils coated with pepsin-digested anti- 
CD Ripley had inhibitors in their sera which were both auto- and isospecific. 
The  possiblity was  entertained,  therefore,  that  something possessing  deter- 
minants of the 5S pepsin fragment of T-globulin (8)  existed free in serum of 
such patients,  x Further studies reported here provide evidence that sera from 
normal individuals or patients with a variety of disorders contain low molecu- 
lar weight 3S--5S fractions of slow gamma mobility capable of inhibiting ag- 
glutination reactions  directed at  the pepsin  site.  Evidence  is  presented  that 
such  lower  molecular  weight  T-globulins  possessing  antigenic  determinants 
present in pepsin-digested T-globulin are present in native human serum. The 
coexistence in normal human sera of antibody to sites on T-globulin exposed 
by pepsin digestion and low molecular weight -},-globulin components possessing 
antigenic features present on the pepsin site provides an example of naturally 
occurring autoreactivity. 
Materials and Methods 
Human sera containing anti-T-globulin factors with specificity  for the pepsin site were 
found by screening 400 sera from hospital in-patients and out-patients. Rh-positive (R1Rx) 
*Supported by Grants from the United States Public Health Service No. 1 T1 AM 5461 
and No. AM 07372 
1The 5S pepsin fragment of ~/-globulin will be designated F(ab')~; the 3.5S S fragment, 
Fab; and the portion of the S fragment  comprised  by heavy chains, Fd according to the ter- 
minology  suggested  by the World  Health Organization (8). 
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cells coated with pepsin-digested incomplete anti-Rh antibody Ripley (1-3, 7) were used in a 
slide agglutination technique as previously described. A group of seven sera with particularly 
high agglutinating  titers for cells coated with pepsin-digested anti-Rh antibody Ripley was 
selected for study. Titers ranged from 1:256 to 1:2048 (Table I). 
Serum fractions were isolated by zone electrophoresis in starch  (9) using 0.1 ionic strength 
Veronal buffer, pH 8.6; by Sephadex G-200 gel filtration in 0.15 ~ NaC1; by sucrose gradient 
ultracentrifugation  for 16 Jar at 35,000 rpm using gradients made 5-200/0, 5-30~, or 10--40~ 
in sucrose (10); and by DEAE Sepbadex chromatography using stepwise elution with 0.02 M 
pH 8.0 phosphate, 0.15 ~ pH 6.8 phosphate, and 0.33 ~ pI-I 4.2 phosphate buffers. 
Inhibition  tests were done as previously described (7) using a dose of agglutinating serum 
consistently showing a 2+ agglutination. Inhibitors  were adjusted  to 1 mg/ec protein con- 
centration  and tested in doubling dilutions, using as agglutinators four different sera V. G., 
L. B., D. K., and M. S. 
5S pepsin fragment of "yG was labeled with ~I, two atoms per mole protein, by the method 
of Helmkamp  (11). The labeled protein was cleared of aggregates by ultracentrifugation  at 
25,000 rpm for 2 hr, and added to various test sera. 
Isolated 3~-globulin  preparations and sera from the patients with high titers of agglutinating 
antibody for the pepsin site were examined in the Model E ultracentrifuge using techniques 
previously described (12, 13). 
Attempts at separation of smaller T-globulin components from the bulk of 7S ~'G employed 
Sephadex G-200 gel filtration at pI-I 4.0, using acetate buffers of 0.1 ionic strength. T-Globulin 
fractions from zone electrophoretic separations were equilibrated  with 0.1 ~x acetate buffer 
pH 4.0 by dialysis and applied to Sephadex G-200 columns. Fractions were tested in immune 
diffusion against rabbit antisera  specific for human Fc fragment,  F(ab')2,  and against  anti- 
F(ab')2 antiserum absorbed with pooled L chains from Cohn fraction II. (7) 
RESULTS 
The studies  contained in this report were prompted by an unexpected find° 
ing obtained with "r-globulin fractions from the first peak of a  DEAE-cellulose 
column  separation  using  the  highest  fitered  serum  (L.B.,  Table  I).  Because 
sucrose density gradient ultracentrifugation  and Sephadex G-200 gel filtration 
had  confirmed  the  predominant  7S  distribution  of  agglutinating  activity  in 
most sera studied, serum L. B. was equilibrated with pit 8.0, 0.02 ~r phosphate 
buffer  and  applied  to  a  DEAE-cellulose  column  similarly  equilibrated.  The 
first fall-through peak with starting buffer contained agglutinating activity as 
shown in Fig.  1. However, when this peak was concentrated by ultrafiltration 
through collodion membranes in the cold at 4°C, the residual concentrate con- 
tained  no aggluntinating activity for cells coated with pepsin-digested  human 
incomplete  antibody Ripley.  The  same  results  were found in  the  case of the 
six other high-titered sera applied to DEAE-cellulose columns. Ultracentrifugal 
examinations  of the  concentrated fall-through  peaks from DEAE-cellulose in 
all  instances  showed  symmetrical  7S  peaks.  This  apparent  disappearance  of 
strong serologic activity suggested  the presence of autologous inhibiting  sub- 
stances. 
Because  serologic activity had  mysteriously disappeared  in starting  buffer 
DEAE-cellulose preparations  from all  high-titered  sera,  inhibition  tests  were 
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centrated, pooled fall-through peaks of DEAE-cellulose columns equilibrated 
with pH 8.0, 0.02  ~  phosphate buffers as inhibitor. The results are shown in 
Table II. It can be seen that in all instances, inhibitory capacity showing both 
iso-  and autospecificity was noted in these preparations.  Pepsin digestion of 
autologous individual 5,-globulins  isolated by zone  electrophoresis  produced 
inhibition to log~ dilution of 12. On the basis of this and previous work utilizing 
TABLE I 
Summary of Clinical and Serological Findings among Seven Patients Showing Unusually  I1igh 
Titers of Agglutinating  Antibody for Cells Coated with Pepsin-Digested Anti-CD 
Antibody Ripley 
Patient 
(sex age) 
L.B. 
(F-62) 
M.S. 
(F-76) 
D.K. 
(M-~4) 
P.S. 
(M-77) 
V.G. 
(F-39) 
J.W. 
(M-75) 
V.F. 
(F4S) 
Diagnosis 
Hamman-Rich  syndrome 
Metastatic carcinoma 
Gm type of whole 
serum 
Gm (1, 4, 5) 
Gm (1, 4, 5) 
Titer  with cells 
coated with 
pepsin-dlgested 
anti-CD Ripley* 
2048 
1024 
Exfoliative  dermatitis 
Chronic lymphatic  leukemia 
Rheumatoid  arthritis 
Carcinoma  of stomach 
Rheumatoid arthritis 
Gm (-1, 4, 5) 
Gm (-1, 4, 5) 
Gm (1, -4, -5) 
Gm (1, 4, 5) 
Gm (--1, 4, 5) 
512 
256 
256 
256 
256 
Molecular 
distribution 
of pepsin site 
a~glutinator 
D  SUCrOSe 
gra~ent ultra- 
centrifugation 
and/or 
;ephadex  G-200 
gel filtration 
7S 
7S, 19S 
7S 
7S, 19S 
7S 
7S 
7S 
* Whole undigested  anti-CD Ripley Gm (1, 4, 5). 
pepsin-digested myeloma proteins (7),  it was possible to estimate that concen- 
trations of 0.03-0.015  mg/cc of material bearing antigenic determinants simi- 
lar to those exposed by pepsin digestion of ~,G were present in the fractions 
from DEAE-cellulose columns tested. 
In addition, initial peaks obtained from three normal sera by DEAE-ceUu- 
lose columns at pH 8.0, 0.02 ~  phosphate were tested for inhibitory capacity. 
In all instances, these fractions displayed distinct inhibitory capacity of log2 
dilution 24  for  several  agglutinators  and  cells  coated  with pepsin-digested 
anti-CD Ripley. Thus, inhibitor could be obtained from normal sera negative 
in the whole state for antibody activity directed at the pepsin site. 
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FIG. 1. Protein curve and agglutinating activity for cells coated with pepsin-digested anti- 
CD Ripley in serum L. B. applied to DEAE-cellulose column equilibrated with pH 8.0, 0.02 
phosphate  buffer. When fractions 11-19 were concentrated in the cold by pressure through 
collodion membranes,  all agglutinating activity for pepsin-digested 7G disappeared.  Essen- 
tially the same result was noted with six other high titered sera. 
TABLE II 
Inhibition  of Agglutination  of Six  Whole Agglutinating  Sera  Reacting with  Cells Coated by 
Pepsin-Digested Anti-CD Ripley by lnitial Peaks from DEAR Column Separations 
I 
Agglutinstor /  Inhibitors tested 
adjusted to 
give 2-3-t-  1st  [  M.S.,  1st  V.G.,  1st 
agglutination Dk/~' peak*  DEAE peak  DEAE  peak 
L.B. 
M.S. 
D.K. 
J.W. 
P.S. 
V.G. 
6§ 
6 
6 
6 
6 
6 
m 
6 
5-6 
5-6 
6 
6 
6 
P.S.  Ist 
DEAR peak 
4 
i-2 
4 
34 
8 
6 
5s pepsin 
digest~ 
L. B., 5S pepsin digest 12 
M. S., 5S pepsin digest 12 
D. K., 5S pepsin digest 12 
J. W., 5S pepsin digest 12 
P. S., 5S pep~n digest  12 
V. G., 5S pepsin digest 12 
* Refers to first peak obtained when serum applied to DEAE column pH 8.0, 0.02 •  phos- 
phate buffer. 
:~ 5S pepsin fragment obtained from pepsin digestion of isolated individual "rG. 
§ Logs dilution of inhibitor effective in inhibiting agglutination. Inhibitors were  adjusted 
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abolition of serologic  agglutinating activity for the pepsin site, it seemed pos- 
sible  that some cleavage had occurred spontaneously within the various 7- 
globulin fractious. That such splitting might occur after storage of isolated 
myeloma proteins for 1-3 wk was apparent in an earlier study (7).  In an at- 
tempt to study this problem further, fresh sera collected from normal blood 
donors were tested within 12 hr of separation from the cells by centrifugation. 
These sera were not subjected to any fractionation procedures, but were tested 
in the neat and diluted state for inhibitory capacity for the pepsin site. 5 of the 
10 sera so tested showed concordant inhibition of three different agglutinators. 
Two other sera inhibited two of the three agglutinators. Thus, in 7 of the 10 
fresh sera tested inhibitory activity for the pepsin site was found. 
Separation Procedure Used in an Attempt  t~ Characterize Autologous Inhibi- 
tors.--The next procedure of separation applied was zone electrophoresis (9). 
The distribution of 7G, ~,A, and 7M, as well as the results of agglutination and 
inhibition reactions are depicted in Fig. 2.  It can be seen that agglutinating 
activity for cells coated with pepsin-digested anti-CD Ripley was detected in 
7-, /3-, and albumin zones of sera which showed agglutinating activity in the 
whole state. In addition, normal sera devoid of agglutinating activity in the 
whole state showed weak agglutination in the albumin region. The reaction in 
the albumin region of both negative and positive sera was not inhibited by 
~,G, 5S pepsin fragment, 3.5S  S fragment, or normal serum albumin. Control 
cells  (including CD  negative cells),  not coated with pepsin-digested anti-CD 
Ripley, were agglutinated to the same degree as coated RxR1 cells, and activity 
toward coated cells was abolished by absorption of the appropriate fractious 
with washed uncoated cells. The nature of this agglutinating activity was not 
investigated  further,  but  resembles  the  albumin-active,  autoagglutinating 
system reported by others (14). 
Of special interest was the finding that distinct inhibition could be found in 
some of the slow starch block fractious devoid of agglutinating activity. Such 
fractious showed precipitius by immune diffusion in some instances with rabbit 
antisera to  F(ab')2,  but not with anti-Fc. The most clearcut inhibition was 
notable in slow T-globulin fractious from zone electrophoretic separations of 
normal serum not possessing agglutinating activity for pepsin-digested, anti- 
CD  Ripley-coated cells  in  the  whole  unfractionated state  (Fig.  2,  normal 
serum V2-180).  Thus, in positive and negative sera, fractions of slow %elec- 
trophoretic mobility or appearing in the fall-through peak of starting buffer 
for DEAE-cellulose columns appeared to contain antigenic determinants simi- 
lar to those involved in the pepsin site antigen. 
The  next  approach  towards  characterizing  inhibiting substances  in  both 
positive and negative sera employed ultracentrifugation in sucrose gradients 
and Sephadex G-200  gel filtration. An example of detection of inhibiting ca- 
pacity after sucrose gradient separation is shown in Fig. 3. Inhibition of several 
agglutinating systems specific for the pepsin site as manifested by cells coated (}.6 
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FZQ.  2. Zone e]ectrophoresis  separations  of two sera, D.  K.  and J.  W.,  showing  distribution 
of  agglutinating  activity  (Agg]ut.)  for  cells  coated  with  pepsin-digested  anti-CD  Ripley  as 
well as fractions of slow 3t-electrophoretic mobility which showed inhibitory capacity (Inhibit.) 
The normal serum V2-180 shown below revealed marked inhibitory capacity in slow 3,-globulin 
fractions. Agglutinations noted in albumin zones were not inhibited by pepsin-digested ,1,_ 
globulin nor by albumin and could be absorbed out with uncoated human cells.  They were, 
therefore, felt to be a separate phenomenon and not studied further. 
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FIO. 3.5-300/0 sucrose gradient separation of serum D. K. possessing agglutinating activity 
(Agglut.) for ceils coated with pepsin-digested anti-CD Ripley predominantly in the 7S region. 
Inhibition .~nhlbit.) was notable in 3S region as well as slight inhibitory effect below 7S region. 
The normal serum V2-180 not possessing detectable agglutinator shows a simi]ar distribution 
of inhibitor. Control experiments with 20 and 30% sucrose revealed that these concentrations 
inhibited the agglutination reaction to a logs dilution of 2. No inhibition was noted with 10 
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with  pepsin-digested  anti-CD  Ripley was  notable  in  fractions  sedimenting 
well above the  7S zone.  However, slight inhibition  was also present in lower 
fractions and since sucrose alone in concentrations of 20-30 % produced slight 
inhibition of agglutination systems, attention was next directed to gel filtration 
experiments. 
Sephadex (;-200 gel filtration of several high titered sera (L. B., D. K., V. G.) 
revealed serologic agglutinating  activity for pepsin-digested,  anti-CD Ripley- 
coated cells only in  7S regions,  whereas two sera separated  by this  method 
(M. S. and P. S.) showed 7S and 19S agglutinating activity. When gel filtration 
fractions of both positive and negative pepsin-agglutinator  sera were studied 
for  their  inhibitory  capacity,  consistent  inhibition  was  noted  in  the  lowest 
molecular  weight  fractions  (5S  or  below).  Of considerable  interest  was  the 
finding  that normal serum V2-180 showed weak but definite  agglutination  in 
19S fractions from the  Sephadex G-200 separation shown in Fig.  4,  whereas 
the whole serum had been negative when tested with pepsin-digested,  incom- 
plete  antibody  Ripley-coated  cells.  These  findings  indicated  concomitant 
agglutinating  activity of  7S  or  19S  distribution  along  with  the  presence  of 
inhibitor 3S-5S in both strongly positive and negative sera. 
An attempt  was next made to obtain low molecular weight material from 
positive and negative sera by Sephadex G-200 gel filtrations in acid buffer at 
pH 4.0.  Slow starch  block fractions from sera such as V2-180  (Fig.  2)  were 
equilibrated by dialysis  against acetate buffer pH 4.0,  0.1 ~r,  and  applied to 
columns equilibrated with the same buffer.  In addition 7S fractions from pre- 
violas Sephadex  G-200  column separations  in  0.15  M saline  were applied  to 
columns equilibrated with the pH 4.0 buffer.  The results of such attempts at 
isolation of inhibitor  are shown in Fig.  5.  It can be seen that  low molecular 
weight inhibiting material appearing in Sephadex G-200 effluents in the 3S-5S 
region could be recovered using these acid buffer conditions.  Indeed, evidence 
for  autologous previously complexed  inhibitor  was  obtained  in  experiments 
such as that shown in the upper portion of Fig. 5. Here the 7S region of a pre- 
vious Sephadex  G-200 separation of serum L.B.  was recycled over Sephadex 
G-200 in pH 4.0 buffer.  Low molecular weight materials capable of inhibiting 
agglutinator L.B. as well as other sera were thereby recovered. 
Further evidence related to the antigenic character of low molecular weight 
-r-globulins  present  in  both  positive  and  negative  pepsin  site-agglutinating 
sera was obtained by inhibition  of precipitation reactions in agar gel. It was 
noted that such lower molecular weight materials inhibited precipitation reac- 
tions apparently preferential for antigenic sites on 5S pepsin fragment but not 
those reacting with Fc. In these reactions antisera made against the 5S pepsin 
fragment of ~/-globulin were absorbed with 3.5S papain S fragment, providing 
an antiserum still showing residual precipitins for 5S pepsin fragment (7). 
Some insight  into possible complexing  of 7S pepsin site agglutinators  with L.B.  G-200  []  Agglut. 
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Fro. 4.  Sephadex G-200 gel filtration separations of two sera, L. B. and M. S., showing 7S and 19S and ?S-ag- 
glutinating activity (Aggiut.)  for cells coated with pepsin-digested anti-CD Ripley. Distinct inhibition (Inhibit.) 
to logs dilution of 5--5 was noted in lower molecular weight fractions 3S-$S. 
The normal serum V2-180 shows weak 19S-agglutinating activity in separated state although it is negative when 
tested as whole serum.  Of interest was concomitant inhibitor in serum V2-180  found in 3S region of Sephadex 
col~!mn separation. Low molecular weight 3S-5S inhibitor was similarly recovered from two other fresh normal sera 
by Sephadex C~200 filtration. 
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5S pepsin-digested "rG-fragments  was sought in two ways. 5S pepsin fragment 
labeled with 1~I was added to various sera both positive and negative in the 
whole state for agglutinating activity against pepsin-digested, anti-CD Ripley- 
coated cells. After incubation at room temperature for 2 hr, ultracentrifugation 
for 16 hr in 10-40 % sucrose gradients failed to show consistent shifts in curves 
of radioactivity when labeled 5S pepsin ^/G-fragments  had been added to sera 
possessing high titers of pepsin site agglutinators. In similar fashion,  5S pepsin 
fragments of "yG when added to whole serum possessing  high titers of agglu- 
tinating  activity for pepsin-digested,  anti-CD  Ripley-coated cells showed no 
discernible  new complexes in the analytical ultracentrifuge. 
Similar  experiments  were performed  using  sera  positive  and  negative  for 
pepsin site-agglutinating  activity and incubation at room temperature for 2 
hr with nSI-labeled 5S pepsin fragment of ~,G. Subsequent zone electrophoresis 
of serum-l~I F(ab'), mixtures in parallel with labeled 5S pepsin fragment alone 
showed no detectable shift in specific electrophoretic mobility of labeled ma- 
terial within sera showing high titers of pepsin site--agglutinating  activity. 
Quantitative precipitin curves were constructed using l~SI-labeled 5S pepsin 
fragment.  Two  sera  with  strong  agglutinating  activity  toward  Rh-positive 
cells coated with pepsin-digested anti-CD  Ripley were selected.  Using 0.2  cc 
of serum and from 0.2  to 86/zg of F(ab')2 per tube no significant  deviation 
from the antigen control could be detected by either protein determination or 
radioactive counting of the washed precipitates. Thus,  no precipitating  anti- 
body for sites revealed on "yG by pepsin digestion was apparent. 
DISCUSSION 
The studies described above were performed primarily because of the rela- 
tively high frequency in normal human sera of agglutinating  antibodies with 
specificity for sites on T-globulin  uncovered by pepsin digestion.  The initial 
reports describing  this type of anti-'t-globulin factor (1) as well as subsequent 
surveys (7) ~ of a large number of sera from normal blood donors and patients 
in hospital have shown that about one third of all human sera contained this 
type of antibody. The incidence  rises precipitously with age, and in sera from 
50 patients between the ages of 60 and 80 yr pepsin site agglutinators  were 
found in some 50%.~ Since this variety of anti-~-globulin factor is relatively 
common among normal human sera, some insight into its genesis and specificity 
seems warranted. 
The clearcut results of autologous inhibitory substances were actually un- 
covered by isolation procedures when DEAE-ceUulose peaks recovered with 
starting pH 8.0, 0.02 ~  phosphate buffers were concentrated and lost serologic 
activity. The most direct demonstration of native inhibitory materials which 
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resembled  or  contained  antigenic  structures  similar  to  those  uncovered  on 
pepsin-digested  TG  was  notable  in  the  zone  electrophoresis  separations  of 
normal sera negative for pepsin site-agglutinating activity in the whole state. 
In all of eight such instances tested,  inhibition was localized to  the slow T- 
globulin fractions of starch block separations. Moreover, a clear estimation of 
the relative size of inhibitory materials present in native serum was gained by 
inhibition  experiments  from  Sephadex  G-200  gel  filtration  separation  pro- 
cedures.  In all instances, predominant inhibitory capacity was  noted in  the 
3S-5S fractions. Some enrichment or relative increment of smaller T-globulin or 
lower molecular weight-inhibiting material was gained when Sephadex G-200 
separations were performed in an acid millieux at pH 4.0 designed to dissociate 
7S antibody from 5S or small antigen. Indeed, acid conditions were not a requi- 
site of the latter and separation of agglutinator from smaller inlfibitor could be 
achieved using 0.15  ~  NaCI Sephadex G-200  column filtration. This suggests 
that ff autologons antigen-antibody complexes exist in normal sera possessing 
high titers of pepsin site-agglutinating activity, their dissociation is  relatively 
easy and perhaps a continuous dynamic phenomenon. 
The  possibility  remains  that  spontaneous  fracture  of  autologous  native 
T-globulins may occur and be responsible for the low molecular weight ma- 
terials  antigenicaUy related  to  the  5S  pepsin fragment and detected in  this 
study. Fresh whole normal human sera tested within several hours of collection 
showed inhibitory capacity for pepsin site agglutination systems. It is  con- 
ceivable that the clotting process itself may actuate some breakdown or altera- 
tion in T-globulln fractions of serum. Pertinent to this entire problem are the 
recent  reports  of  demonstrable  proteolytic  activity  in  various  T-globulin 
preparations (15,  16).  8 The lability or ease of exposure of the relatively buried 
antigenic  determinant  on  pepsin-digested  T-globulin  therefore  becomes  im- 
portant.  Studies by Waller  4 have recently indicated that complete  digestion 
of the Fc or F fragment may not be necessary to expose the pepsin site antigen. 
The ease of exposure of this antigenic structure and the large proportion of 
normal human sera containing antibody directed towards it are of interest. 
The  exact nature  of  the  3S-5S  autologons inhibitor present  in  sera  with 
antibodies directed at the pepsin site is still not clear. The technique of inhi- 
bition of agglutination shown previously to be capable of detecting 5S pepsin- 
digested T-globulin or pepsin fragments of various myeloma proteins in log2 
dilution  of  11-12 or  0.0008  mg/cc  (7)  was  certainly  much  more  sensitive 
than immune diffusion or agar gel precipitation methods used in general fashion 
to calibrate distribution of TG-antigenic determinants. That autologous inhibi- 
tor was not necessarily antigen-antibody complexes was clear from its distri- 
8B. Robert and R. S. Blockman.  1966. Studies  on the proteolytic  activity of T-preparations. 
Information  Exchange  Group No. 5. Scientific  Memo  No. 207. 
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bution in  Sephadex  G-200  gel filtration  experiments.  Harboe and  coworkers 
(2)  and  recently Natvig  (3)  have emphasized  the  concurrent  appearance  of 
anti-'r-giobulin factors showing specificity for pepsin-digested ~/G, as well as 
sites uncovered or juxtaposed by combination of antibody with antigen;  so- 
called "anti-antibodies" (4, 5). 
Recent reports  (3,  17)  have  demonstrated  some apparent  selective speci- 
ficity of pepsin site agglutinators for pepsin-digested anti-Rh incomplete anti- 
bodies seemingly dependent on the Gm type of the native anti-Rh serum. Such 
specificity was  not  readily apparent  in previous  studies  (1,  7)  but may be 
directly implicated in the studies of autologous inhibition presented here.  It is 
of interest that the Gm types of the native sera studied here were of disparate 
types, but that all contained at least one Gm factor present in the whole anti- 
CD  Ripley used after pepsin digestion to coat Rh-positive cells.  Four high 
titered  sera agglutinating  pepsin-digested,  anti-CD  Ripley-coated cells  were 
Gm (1, 4, 5). Three were Gm (--1, 4, 5), and one was Gm (1,  --4,  --5)  (18). 
Further  study using  a  broader  spectrum  of single  pepsin  digested  anti-Rh 
antibodies is needed to clarify this point. Pertinent to this matter are the find- 
ings in Table H, where some variation in inhibitory capacity was notable using 
DEAE-cellulose-isolated ,r-globulin  fractions  of serum  P.S.  Gm  (--1,  4,  5). 
Marked autospecificity, log2 dilution of 8, was notable for inhibition of serum 
P.S.,  but deficiency in inhibition  for serum M.S.  Gm  (1,  4,  5)  was present. 
Since low molecular weight inhibitor was present in all positive agglutinating 
sera studied, it seems likely that the primary specificity of pepsin site agglu- 
tinators is directed toward autologous determinants. 
Finally,  recent  studies  on  low  molecular  weight  ~/-globuHn.~ (19-21)  are 
directly pertinent to our finding  of native serum 3S-5S inhibitors of -r-mobil- 
ity.  The  studies  by Fireman  and  coworkers  (20)  as  well  as  later  extensive 
studies of 3S plasma o/-globulins by Ikenaka,  Gitlin,  and Schmld (21) revealed 
immunologic  cross-reactions  between 7S ~,G, S fragment,  and the 3S 3~-globu  - 
lins isolated from plasma. Peptide maps as well as amino acid composition of 
these 3S ~/-globulin serum components indicated distinct  differences  from B 
chain or Bence Jones proteins. These differences make it seem unlikely that the 
3S ^/-globulins  studied by these workers were directly derived as metabolic 
products or fragments of ~G.  Study of a sample of the 3S ~/-globulin kindly 
furnished by Dr. Schm~d showed that this material did not inhibit pepsin site 
agglutination  reactions  in concentrations  up  to  2 mg/cc.  Another  report  of 
3.5S  ~,-globulin  antibodies  has  recently appeared  (22).  These  studies  along 
with a  number  of previous reports provide evidence that ~,-globulin  compo- 
nents of low molecular weight may exist in serum (23, 24). Relatively elevated 
levels of free L chains  have recently been described by several groups (25, 26) 
in the case of serum sickness  and disseminated lupus erythematosus. Subse- 
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with multiple  myeloma  (27).  The concept of free antigen  or presumptive  po- 
tential  antigen  such  as  the  pepsin  fragment  of  7-globulin  being  present  or 
complexed in serum is somewhat new. A  situation  would then be obtained in 
which patients  with high titers of antibody or high levels of pepsin site agglu- 
tinators  may have formed antibodies  to determinants  of ~/G revealed  or un- 
covered during  autologous immunoglobulin  catabolism.  If antibodies  showing 
specificity for  5S  pepsin  digested  7-globulin  or  its  Fd  determinants  (7,  17) 
are  present  in  a  large  proportion  of normal  random  human  sera  and  if  the 
initiating  antigen  be autologous "y-globulin antigenic  structures  present  as  a 
by-product  of T-globulin  catabolism,  then  a  physiogenic or normal  autoanti- 
body does  not  seem particularly  disquieting.  Further  investigation  into  the 
physiologic  function  of  antibodies  showing  pepsin  site  specificity is  needed. 
Whether such factors are operative in monitoring  catabolic rates of 7G-globu- 
lin  would be  of interest.  This  is  particularly  pertinent  in  view of  the  rapid 
turnover  and  elimination  of 5S pepsin fragment previously reported  (28,  29). 
However,  more  recent  studies  by this  same  group  (30)  have  indicated  that 
complexes of specific Fab  and  antigen  or  F(ab')~  and  antigen  (BSA)  persist 
longer  in the circulating  state than  Fab or F(ab')~ alone.  These latter  obser- 
vations  are of particular  importance  to some of the findings  in  the currently 
reported study. 
SUMMARY 
Many sera from normal individuals  as well as patients  with various disease 
states  contain  agglutinating  antibodies  which  show  specificity for  antigenic 
determinants  of T-globulin revealed by pepsin digestion  at pH 4.1.  Sera con- 
taining  such  agglutinating  activity  as  well as  sera  negative  for  these  agglu- 
tinators  contain low molecular weight  (3S-5S)  components of slow -r-mobility 
which  inhibit  these  agglutination  reactions.  Low molecular  weight  inhibitors 
show  both  auto-  and  isospecificity,  and  are  antigenically  related  to  the  5S 
pepsin  fragment  of  7-globulin.  A  common  situation  is  thereby  revealed  in 
which human anti-7-globulin antibodies showing specificity for pepsin-digested 
T-globulins are  present  in serum along  with  low molecular  weight T-globulin 
components  capable  of  inhibition.  Autoreactivity  or  autospecificity  of  such 
anti-7-globulin  factors  is  a  phenomenon  shared  by both  normal  human  sera 
and sera from patients  with various disease states. 
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